retatrutide benefits clinical trial retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works retatrutide benefits clinical trials retatrutide

Baseline Cardiovascular Assessment Before initiating therapy, clinicians should obtain a comprehensive cardiovascular history, including previous cardiac events, arrhythmias, hypertension, and family history of premature cardiovascular disease

Liposuction is another popular choice for individuals seeking to rid themselves of unwanted fat

2028 Translation and linguistic validation of the GENDER-Q into French for use in Canada Trisia Breitkopf 1 , Sylvie Cornacchi 1 , Ines Ndzana Siani 1 , Julia Sapin-Leduc 2 , Flavie Guibert-Pich 2 , Hanya Obsieh 1 , Charlene Rae 1 , Yi Wang 1 , Alexis Laungani 2 , Pierre Brassard 2 , Manraj Kaur 3 , Andrea Pusic 3 , Anne Klassen 1 1 Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada, 2 GrS Montral, Montral, Quebec, Canada, 3 Patient-Reported Outcomes and Values, & Experience Center (PROVE), Brigham and Womens Hospital, Harvard Medical School, Boston, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2028 Aims The GENDER-Q is a new patient-reported outcome measure (PROM) that measures outcomes in gender-affirming care

The US Food and Drug Administration approved Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice

Check out our FAQ Page